GB1442564A - Process for preparing inactivated hb ag vaccine - Google Patents
Process for preparing inactivated hb ag vaccineInfo
- Publication number
- GB1442564A GB1442564A GB3604274A GB3604274A GB1442564A GB 1442564 A GB1442564 A GB 1442564A GB 3604274 A GB3604274 A GB 3604274A GB 3604274 A GB3604274 A GB 3604274A GB 1442564 A GB1442564 A GB 1442564A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- stabilizer
- preparing inactivated
- inactivated
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000003381 stabilizer Substances 0.000 abstract 2
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP164874A JPS5523253B2 (enrdf_load_stackoverflow) | 1973-12-28 | 1973-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1442564A true GB1442564A (en) | 1976-07-14 |
Family
ID=11507324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3604274A Expired GB1442564A (en) | 1973-12-28 | 1974-08-15 | Process for preparing inactivated hb ag vaccine |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS5523253B2 (enrdf_load_stackoverflow) |
| CA (1) | CA1023663A (enrdf_load_stackoverflow) |
| CH (1) | CH611338A5 (enrdf_load_stackoverflow) |
| DE (1) | DE2440927C3 (enrdf_load_stackoverflow) |
| FR (1) | FR2256247B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1442564A (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0011032A1 (en) * | 1978-10-30 | 1980-05-14 | Merck & Co. Inc. | Method for isolation of HBsAg |
| EP0130619A3 (en) * | 1983-07-05 | 1985-04-10 | Chemo Sero Therapeut Res Inst | Hepatitis b vaccine and method for its preparation |
| AU599007B2 (en) * | 1984-10-02 | 1990-07-12 | New York Blood Center, Inc., The | Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS591981B2 (ja) * | 1976-08-27 | 1984-01-14 | 株式会社ミドリ十字 | ＨＢｓ抗体検出用受身赤血球凝集試験用担体の製造方法 |
| JPS6094917A (ja) * | 1983-10-28 | 1985-05-28 | Green Cross Corp:The | Ｂ型肝炎感染予防用ワクチンの製造方法 |
| NL8401066A (nl) * | 1984-04-04 | 1985-11-01 | Stichting Centraal Lab | Werkwijze ter bereiding van preparaten, die de humorale en cellulaire immuunreaktiviteit vergroten. |
-
1973
- 1973-12-28 JP JP164874A patent/JPS5523253B2/ja not_active Expired
-
1974
- 1974-08-14 CA CA207,018A patent/CA1023663A/en not_active Expired
- 1974-08-15 GB GB3604274A patent/GB1442564A/en not_active Expired
- 1974-08-27 FR FR7429290A patent/FR2256247B1/fr not_active Expired
- 1974-08-27 DE DE2440927A patent/DE2440927C3/de not_active Expired
- 1974-12-10 CH CH1637074A patent/CH611338A5/xx not_active IP Right Cessation
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0011032A1 (en) * | 1978-10-30 | 1980-05-14 | Merck & Co. Inc. | Method for isolation of HBsAg |
| EP0130619A3 (en) * | 1983-07-05 | 1985-04-10 | Chemo Sero Therapeut Res Inst | Hepatitis b vaccine and method for its preparation |
| AU572162B2 (en) * | 1983-07-05 | 1988-05-05 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Hepatitis b vaccine |
| AU599007B2 (en) * | 1984-10-02 | 1990-07-12 | New York Blood Center, Inc., The | Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2440927B2 (de) | 1978-04-20 |
| FR2256247A1 (enrdf_load_stackoverflow) | 1975-07-25 |
| DE2440927C3 (de) | 1978-12-07 |
| DE2440927A1 (de) | 1975-07-03 |
| CH611338A5 (en) | 1979-05-31 |
| JPS5095420A (enrdf_load_stackoverflow) | 1975-07-29 |
| JPS5523253B2 (enrdf_load_stackoverflow) | 1980-06-21 |
| CA1023663A (en) | 1978-01-03 |
| FR2256247B1 (enrdf_load_stackoverflow) | 1976-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5461112A (en) | Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component | |
| OA04704A (fr) | Procédé de préparation de nouveaux vaccins. | |
| IE38825L (en) | Stabile viral preparation | |
| PT70610A (fr) | Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient | |
| ES416573A1 (es) | Metodo de extraer mucopolisacaridos de tejidos conjuntivos de animales. | |
| SE8005824L (sv) | Vaccin av hudparvovirus samt forfarande for dess framstellning | |
| GB1442564A (en) | Process for preparing inactivated hb ag vaccine | |
| DK131324B (da) | Fremgangsmåde til fremstilling af et lægemiddel i form af en klar, steril vandig opløsning. | |
| SE7602871L (sv) | Vaccin for aktiv immunisering | |
| YU328073A (en) | Process for obtaining a live vaccine of the virus of infectious bovine rhinotracheitis | |
| JPS51118820A (en) | A process for preparing heat stable macroglobulin | |
| CA983851A (en) | Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same | |
| NL7413642A (nl) | Werkwijze voor de bereiding van een virus subeenheid vaccin. | |
| RO69550A (ro) | Procedeu pentru prepararea unor derivati ai acizilor pirimido-(4,5 b)chinolin-4(3h)-on-2-carboxilici | |
| JPS51118825A (en) | A process for preparing heat stable iga and igm | |
| IT1030102B (it) | Procedimento per il trattamento dei residui di distilleria, particolarmente per il ricupero di materie coloranti da vinacce e simili | |
| SE428644B (sv) | Forfarande for vermebehandling av den vattenhaltiga losningen, som innehaller human haptoglobin for att inaktivera hepatitis b antigen | |
| Yan et al. | Studies on the passage and adaptation of a rabies street virus in mice brain and human diploid cell strain. | |
| FR2335237A1 (fr) | Vaccin contre l'hepatite virale de type b et procede de preparation de ce vaccin | |
| SU507582A1 (ru) | Способ получени ацетилхолинэстеразы | |
| CA1030449A (en) | Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same | |
| HU171544B (hu) | Sposob poluchenija inaktivaciej vakcin virusov i bakterij | |
| NL7408579A (en) | Vaccine against respiratory infections esp in horses - contg an adsorbed, killed suspension of reovirus in water | |
| GB770852A (en) | Vaccine products and process of producing the same | |
| GB1434181A (en) | Vaccine for the prevention and treatment of vascular conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19920815 |